June 26, 2017 / 12:15 PM / 2 months ago

BRIEF-Trovagene announces expansion of key claims for its NPM1 patent portfolio

June 26 (Reuters) - Trovagene Inc

* Trovagene announces expansion of key claims for its npm1 patent portfolio for acute myeloid leukemia

* Trovagene inc - trovagene plans to initiate clinical trials of pcm-075 in aml, Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below